BMY analyst estimates
Bristol-Myers Squibb (BMY) analyst ratings, the average price target and its range, and every firm's latest call.
BMY analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 30, 2026 | Truist Financial | Truist Securities Bullish on Bristol-Myers Squibb Co. (BMY): 'we expect multiple readouts by YE2026/2027 to provide inflection points' | $70.00 |
| Oct 26, 2026 | Piper Sandler | Bristol Myers price target lowered to $78 from $82 at Piper Sandler | $78.00 |
| Oct 12, 2026 | Jefferies | Bristol Myers price target raised to $76 from $73 at Jefferies | $76.00 |
| Oct 8, 2026 | Cantor Fitzgerald | Bristol Myers price target lowered to $53 from $59 at Cantor Fitzgerald | $53.00 |
| Oct 7, 2026 | Morgan Stanley | Bristol Myers price target raised to $41 from $40 at Morgan Stanley | $41.00 |
| Oct 5, 2026 | Leerink Partners | Leerink downgrades Bristol Myers to Market Perform, lowers target to $59 | $59.00 |
| Sep 23, 2026 | Goldman Sachs | Goldman Sachs on Bristol-Myers Squibb Co. (BMY): 'Complicated Setup for Upcoming Admilparant Phase 3 IPF Readout' | $63.00 |
| Sep 16, 2026 | Piper Sandler | Bristol Myers price target raised to $82 from $75 at Piper Sandler | $82.00 |
| Sep 10, 2026 | HSBC | Bristol Myers price target raised to $65 from $60 at HSBC | $65.00 |
| Aug 5, 2026 | Argus Research | Bristol Myers upgraded to Buy from Hold at Argus | $75.00 |
| Aug 5, 2026 | Roth Capital | Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls | $75.00 |
| Aug 4, 2026 | RBC Capital | RBC Capital on Bristol-Myers Squibb's (BMY) AZN Deal Feedback | $64.00 |
| Jul 31, 2026 | Wells Fargo | Bristol Myers price target raised to $65 from $60 at Wells Fargo | $65.00 |
| Jul 31, 2026 | Guggenheim | Bristol Myers price target raised to $75 from $72 at Guggenheim | $75.00 |
| Jul 31, 2026 | Cantor Fitzgerald | Bristol Myers price target raised to $59 from $54 at Cantor Fitzgerald | $59.00 |
- 17 firms rate BMY: 8 buy, 8 hold, 1 sell.
- The average price target is $66.08 from 13 analysts, from $41.00 to $78.00.
Updated 2026-11-02 17:51 UTC